Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial

References

• VaziriNDHollanderDHungEKVoMDadufalzaLImpaired intestinal absorption of vitamin D3 in azotemic ratsAm J Clin Nutr19833734034066299090
   PubMed Web of Science ®Google Scholar
• MoeSDruekeTCunninghamJDefinition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO)Kidney Int200669111945195316641930
   PubMed Web of Science ®Google Scholar
• BerndtTJSchiaviSKumarR“Phosphatonins” and the regulation of phosphorus homeostasisAm J Physiol Renal Physiol20052896F1170F118216275744
   PubMed Web of Science ®Google Scholar
• RitzEGrossMLDikowRRole of calcium-phosphorous disorders in the progression of renal failureKidney Int Suppl200599S66S70
   Web of Science ®Google Scholar
• MehrotraRKermahDASaluskyIBChronic kidney disease, hypovitaminosis D, and mortality in the United StatesKidney Int200976997798319657329
   PubMed Web of Science ®Google Scholar
• National Kidney FoundationK/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney diseaseAm J Kidney Dis2003424 suppl 3S1S20114520607
   PubMed Web of Science ®Google Scholar
• OliveiraRBCancelaALGraciolliFGEarly control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?Clin J Am Soc Nephrol20105228629119965540
   PubMed Web of Science ®Google Scholar
• EvenepoelPMeijersBViaeneLFibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidismClin J Am Soc Nephrol2010571268127620448073
   PubMed Web of Science ®Google Scholar
• HuPXuanQHuBLuLWangJQinYHFibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney diseaseInt J Biol Sci20128566367122606047
   PubMed Web of Science ®Google Scholar
• MathewJSSachsMCKatzRFibroblast growth factor-23 and incident atrial fibrillation: the multi-ethnic study of atherosclerosis (MESA) and the cardiovascular health study (CHS)Circulation2014130429830724920722
   PubMed Web of Science ®Google Scholar
• KendrickJCheungAKKaufmanJSFGF-23 associates with death, cardiovascular events, and initiation of chronic dialysisJ Am Soc Nephrol201122101913192221903574
   PubMed Web of Science ®Google Scholar
• IsakovaTXieHYangWFibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney diseaseJAMA2011305232432243921673295
   PubMed Web of Science ®Google Scholar
• LiuSTangWZhouJFibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin DJ Am Soc Nephrol20061751305131516597685
   PubMed Web of Science ®Google Scholar
• WolfMUpdate on fibroblast growth factor 23 in chronic kidney diseaseKidney Int201282773774722622492
   PubMed Web of Science ®Google Scholar
• HausslerMRWhitfieldGKKanekoIThe role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axisRev Endocr Metab Disord2012131576921932165
   PubMed Web of Science ®Google Scholar
• FukagawaMKazamaJJWith or without the kidney: the role of FGF23 in CKDNephrol Dial Transplant20052071295129815840677
   PubMed Web of Science ®Google Scholar
• ShimadaTYamazakiYTakahashiMVitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolismAm J Physiol Renal Physiol20052895F1088F109515998839
   PubMed Web of Science ®Google Scholar
• RazzaqueMSThe FGF23-Klotho axis: endocrine regulation of phosphate homeostasisNat Rev Endocrinol200951161161919844248
   PubMed Web of Science ®Google Scholar
• Gonzalez-ParraEGonzalez-CasausMLGalanALanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patientsNephrol Dial Transplant20112682567257121436379
   PubMed Web of Science ®Google Scholar
• YilmazMISonmezASaglamMComparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trialAm J Kidney Dis201259217718522137672
   PubMed Web of Science ®Google Scholar
• LinHHLiouHHWuMSLinCYHuangCCLong-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patientsNephrology (Carlton)2014191167267825113414
   PubMed Web of Science ®Google Scholar
• BlockGAWheelerDCPerskyMSEffects of phosphate binders in moderate CKDJ Am Soc Nephrol20122381407141522822075
   PubMed Web of Science ®Google Scholar
• SorianoSOjedaRRodriguezMThe effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patientsClin Nephrol2013801172223391319
   PubMed Web of Science ®Google Scholar
• ChangYMTsaiSCShiaoCCEffects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patientsClin Exp Nephrol Epub2016127
   Web of Science ®Google Scholar
• LevineBSKleemanCRFelsenfeldAJThe journey from vitamin D-resistant rickets to the regulation of renal phosphate transportClin J Am Soc Nephrol20094111866187719808223
   PubMed Web of Science ®Google Scholar
• BarthelTKMathernDRWhitfieldGK1,25-dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolismJ Steroid Biochem Mol Biol20071033–538138817293108
   PubMed Web of Science ®Google Scholar
• QuarlesLDSkeletal secretion of FGF-23 regulates phosphate and vitamin D metabolismNat Rev Endocrinol20128527628622249518
   PubMed Web of Science ®Google Scholar
• NormanAWIntestinal calcium absorption: a vitamin D-hormone-mediated adaptive responseAm J Clin Nutr19905122903002407100
   PubMed Web of Science ®Google Scholar
• WoodRJTchackLTapariaS1,25-dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell lineBMC Physiol200111111545681
   PubMedGoogle Scholar
• ChristakosSDhawanPPortaAMadyLJSethTVitamin D and intestinal calcium absorptionMol Cell Endocrinol20113471–2252921664413
   PubMed Web of Science ®Google Scholar
• ZelinskiJMSykesDEWeiserMMThe effect of vitamin D on rat intestinal plasma membrane CA-pump mRNABiochem Biophys Res Commun199117927497551898397
   PubMed Web of Science ®Google Scholar
• ChristakosSGabrielidesCRhotenWBVitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations, and molecular biologyEndocr Rev19891013262666110
   PubMed Web of Science ®Google Scholar
• Burnett-BowieSALederBZHenaoMPBaldwinCMHaydenDLFinkelsteinJSRandomized trial assessing the effects of ergocalciferol administration on circulating FGF23Clin J Am Soc Nephrol20127462463122300739
   PubMed Web of Science ®Google Scholar
• AlvarezJALawJCoakleyKEHigh-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trialAm J Clin Nutr201296367267922854402
   PubMed Web of Science ®Google Scholar
• Wesseling-PerryKPereiraRCSahneySCalcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidismKidney Int201179111211920861820
   PubMed Web of Science ®Google Scholar
• VervloetMGvan IttersumFJButtlerRMHeijboerACBlankensteinMAter WeePMEffects of dietary phosphate and calcium intake on fibroblast growth factor-23Clin J Am Soc Nephrol20116238338921030580
   PubMed Web of Science ®Google Scholar
• KobayashiKImanishiYMiyauchiARegulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidismEur J Endocrinol20061541939916381997
   PubMed Web of Science ®Google Scholar
• Rodriguez-OrtizMELopezIMunoz-CastanedaJRCalcium deficiency reduces circulating levels of FGF23J Am Soc Nephrol20122371190119722581996
   PubMed Web of Science ®Google Scholar
• MaiMLEmmettMSheikhMSSanta AnaCASchillerLFordtranJSCalcium acetate, an effective phosphorus binder in patients with renal failureKidney Int19893646906952811066
   PubMed Web of Science ®Google Scholar
• El-AgroudyAEEl-HusseiniAAEl-SayedMGhoneimMAPreventing bone loss in renal transplant recipients with vitamin DJ Am Soc Nephrol200314112975297914569109
   PubMed Web of Science ®Google Scholar
• MoeSMDisorders involving calcium, phosphorus, and magnesiumPrim Care2008352215237vvi18486714
   PubMed Web of Science ®Google Scholar